Evidence map›Paper›PMID 35196565›Full record

ArticleNeuroImage2022

Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging.

Krishnakant V Saboo, Chang Hu, Yogatheesan Varatharajah, Scott A Przybelski, Robert I Reid, Christopher G Schwarz, Jonathan Graff-Radford, David S Knopman, Mary M Machulda, Michelle M Mielke and 7 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Krishnakant V SabooUniversity of Illinois, Urbana-Champaign, IL, United States; Mayo Clinic, Rochester MN, United States.
Chang HuUniversity of Illinois, Urbana-Champaign, IL, United States; Mayo Clinic, Rochester MN, United States.
Yogatheesan VaratharajahUniversity of Illinois, Urbana-Champaign, IL, United States; Mayo Clinic, Rochester MN, United States.
Scott A PrzybelskiMayo Clinic, Rochester MN, United States.
Robert I ReidMayo Clinic, Rochester MN, United States.
Christopher G SchwarzMayo Clinic, Rochester MN, United States.
Jonathan Graff-RadfordMayo Clinic, Rochester MN, United States.
David S KnopmanMayo Clinic, Rochester MN, United States.
Mary M MachuldaMayo Clinic, Rochester MN, United States.
Michelle M MielkeMayo Clinic, Rochester MN, United States.
Ronald C PetersenMayo Clinic, Rochester MN, United States.
Paul M ArnoldUniversity of Illinois, Urbana-Champaign, IL, United States; Carle Foundation Hospital, Urbana IL, United States.
Gregory A WorrellMayo Clinic, Rochester MN, United States.
David T JonesMayo Clinic, Rochester MN, United States.
Clifford R JackMayo Clinic, Rochester MN, United States.
Ravishankar K IyerUniversity of Illinois, Urbana-Champaign, IL, United States. Electronic address: rkiyer@illinois.edu.
Prashanthi VemuriMayo Clinic, Rochester MN, United States. Electronic address: vemuri.prashanthi@mayo.edu.
Mayo Clinic in Arizona · USUniversity of Illinois Urbana-Champaign · USCarle Foundation Hospital · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Investigating Resistance and Resilience Mechanisms in Alzheimer’s DiseaseR01AG056366 · NIA · MAYO CLINIC ROCHESTER · PI PRASHANTHI VEMURI · 2017 to 2026
$7.0M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Development, Validation, and Application of an Imaging based CVD ScaleR01NS097495 · NINDS · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 2016 to 2020
$2.9M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG041851NIA NIH HHS R01 AG056366NIA NIH HHS R33 AG058738NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786NINDS NIH HHS R01 NS097495
6 · The paper itself

Abstract

Specific brain structures (gray matter regions and white matter tracts) play a dominant role in determining cognitive decline and explain the heterogeneity in cognitive aging. Identification of these structures is crucial for screening of older adults at risk of cognitive decline. Using deep learning models augmented with a model-interpretation technique on data from 1432 Mayo Clinic Study of Aging participants, we identified a subset of brain structures that were most predictive of individualized cognitive trajectories and indicative of cognitively resilient vs. vulnerable individuals. Specifically, these structures explained why some participants were resilient to the deleterious effects of elevated brain amyloid and poor vascular health. Of these, medial temporal lobe and fornix, reflective of age and pathology-related degeneration, and corpus callosum, reflective of inter-hemispheric disconnection, accounted for 60% of the heterogeneity explained by the most predictive structures. Our results are valuable for identifying cognitively vulnerable individuals and for developing interventions for cognitive decline.

Indexed as

Cognitive AgingCognitive DysfunctionDeep LearningAgedAgingBrainCognitionHumansMagnetic Resonance ImagingBrain reserveCognitive agingCognitive heterogeneityDeep learning

Identifiers

PMID35196565
PMCPMC9045384
OpenAlexW4213144871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.